Viatris acquires Famy Life Sciences ophthalmology business for Rs 2,500 crore Ruchika Sharma8 Nov 2022 8:00 AM GMTViatris is taking over a business consisting of a strong ophthalmic portfolio of phase 3 clinical assets in diseases such as dry eye, presbyopia, and...
Topical ophthalmic antibiotics not tied with increased adverse neonatal outcomes: Study Dr. Shravani Dali1 Jun 2022 4:15 AM GMTTreatment of chalazia, hordeola, blepharitis, and bacterial conjunctivitis with topical ophthalmic antibiotics does not increase the risk of adverse...
Augmented Intense Pulse Light therapy may improve Meibomian gland dysfunction and dry eye disease MD Editorial Team4 Dec 2021 3:30 AM GMTSandy Zhang-Nunes and colleagues discovered that intense pulsed light (IPL) has shown great potential in the treatment of refractory Meibomian gland...
Dupilumab may Raise Risk of Ocular Disease in Atopic Dermatitis Patients: Study Josepha James8 Jun 2021 3:45 AM GMTDupilumab is the first human monoclonal antibody approved for the treatment of atopic dermatitis (AD). However, a recent study suggests that the use...
